JULIET L CHHOR

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health NORTHFIELD, NJ NPI 1962279836

General Payments — all program years on this page

$776.53

  • Category: General Payments
  • Program years: PY2024
  • Record count: 19
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $776.53 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $776.5319

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Axsome Therapeutics, Inc. $272.905
Alkermes, Inc. $203.536
Otsuka America Pharmaceutical, Inc. $166.016
ABBVIE INC. $116.361
Novo Nordisk AS $17.731

By program year

Program yearAmountRecords
2024 $776.5319

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100293832 Novo Nordisk Inc $17.73 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106911044 ABBVIE INC. $116.36 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119043939 Otsuka America Pharmaceutical, Inc. $17.31 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119043941 Otsuka America Pharmaceutical, Inc. $87.65 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119043943 Otsuka America Pharmaceutical, Inc. $13.09 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119043945 Otsuka America Pharmaceutical, Inc. $19.52 10/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119043947 Otsuka America Pharmaceutical, Inc. $14.12 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119043949 Otsuka America Pharmaceutical, Inc. $14.32 11/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120479198 Alkermes, Inc. $16.57 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120479200 Alkermes, Inc. $16.06 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120479202 Alkermes, Inc. $16.13 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120479204 Alkermes, Inc. $119.97 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120479206 Alkermes, Inc. $18.17 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120479208 Alkermes, Inc. $16.63 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148373420 Axsome Therapeutics, Inc. $3.64 04/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148373422 Axsome Therapeutics, Inc. $22.83 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148373424 Axsome Therapeutics, Inc. $107.67 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148373426 Axsome Therapeutics, Inc. $121.85 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148373428 Axsome Therapeutics, Inc. $16.91 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.